AstraZeneca Appoints Michel Demare as New Chairman-Designate
29 Julho 2022 - 4:19AM
Dow Jones News
By Sabela Ojea
AstraZeneca PLC said Friday that its independent nonexecutive
director and chairman of the company's remuneration committee
Michel Demare has been appointed as the new chairman-designate of
the board.
The Anglo-Swedish pharma giant reiterated that the current
chairman of the board, Leif Johansson, will be retiring in April
2023.
"Michel's appointment will take effect immediately on Leif's
retirement allowing for a managed handover period over the coming
months," AstraZeneca said.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
July 29, 2022 03:04 ET (07:04 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Astrazeneca (LSE:AZN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024